These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6732213)

  • 21. Disposition of famotidine in renal insufficiency.
    Halstenson CE; Abraham PA; Opsahl JA; Chremos AN; Keane WF; Matzke GR
    J Clin Pharmacol; 1987 Oct; 27(10):782-7. PubMed ID: 3429684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis.
    Blevins RD; Halstenson CE; Salem NG; Matzke GR
    Antimicrob Agents Chemother; 1984 May; 25(5):603-6. PubMed ID: 6732227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Steady-state pharmacokinetics of intramuscular imipenem-cilastatin in elderly patients with various degrees of renal function.
    Pietroski NA; Graziani AL; Lawson LA; Bland JA; Rogers JD; MacGregor RR
    Antimicrob Agents Chemother; 1991 May; 35(5):972-5. PubMed ID: 1854179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of famotidine, a new H2-receptor antagonist, in relation to renal function.
    Takabatake T; Ohta H; Maekawa M; Yamamoto Y; Ishida Y; Hara H; Nakamura S; Ushiogi Y; Kawabata M; Hashimoto N
    Eur J Clin Pharmacol; 1985; 28(3):327-31. PubMed ID: 2861096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of vancomycin in normal subjects and in patients with reduced renal function.
    Moellering RC; Krogstad DJ; Greenblatt DJ
    Rev Infect Dis; 1981; 3 suppl():S230-5. PubMed ID: 7342286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disposition of cefmetazole in healthy volunteers and patients with impaired renal function.
    Halstenson CE; Guay DR; Opsahl JA; Hirata CA; Olanoff LS; Novak E; Ko H; Cathcart KS; Matzke GR
    Antimicrob Agents Chemother; 1990 Apr; 34(4):519-23. PubMed ID: 2344159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steady-state intravenous pharmacokinetics of pirenzepine in patients with differing degrees of renal dysfunction.
    Krakamp B; Tanswell P; Vogel H; Bozler G
    Eur J Clin Pharmacol; 1989; 36(1):75-8. PubMed ID: 2917593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of carumonam (AMA-1080) in patients with impaired renal function and in those undergoing hemodialysis.
    Konishi K; Suzuki H; Saruta T; Deguchi N; Fugono T
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1048-52. PubMed ID: 1929242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pentostatin pharmacokinetics and dosing recommendations in patients with mild renal impairment.
    Lathia C; Fleming GF; Meyer M; Ratain MJ; Whitfield L
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):121-6. PubMed ID: 12172976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of intravenous ciprofloxacin in normal and renally impaired subjects.
    Shah A; Lettieri J; Blum R; Millikin S; Sica D; Heller AH
    J Antimicrob Chemother; 1996 Jul; 38(1):103-16. PubMed ID: 8858462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of pregabalin in subjects with various degrees of renal function.
    Randinitis EJ; Posvar EL; Alvey CW; Sedman AJ; Cook JA; Bockbrader HN
    J Clin Pharmacol; 2003 Mar; 43(3):277-83. PubMed ID: 12638396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of vancomycin: observations in 28 patients and dosage recommendations.
    Rotschafer JC; Crossley K; Zaske DE; Mead K; Sawchuk RJ; Solem LD
    Antimicrob Agents Chemother; 1982 Sep; 22(3):391-4. PubMed ID: 7137982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreasing the time to achieve therapeutic vancomycin concentrations in critically ill patients: developing and testing of a dosing nomogram.
    Baptista JP; Roberts JA; Sousa E; Freitas R; Deveza N; Pimentel J
    Crit Care; 2014 Dec; 18(6):654. PubMed ID: 25475123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New recommendations for vancomycin dosage for patients with MRSA pneumonia with various degrees of renal function impairment.
    Yoshida M; Yasuda N; Nishikata M; Okamoto K; Uchida T; Matsuyama K
    J Infect Chemother; 2005 Aug; 11(4):182-8. PubMed ID: 16133709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased vancomycin clearance in patients with congestive heart failure.
    Shimamoto Y; Fukuda T; Tominari S; Fukumoto K; Ueno K; Dong M; Tanaka K; Shirasaka T; Komori K
    Eur J Clin Pharmacol; 2013 Mar; 69(3):449-57. PubMed ID: 22791272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temafloxacin pharmacokinetics in subjects with normal and impaired renal function.
    Granneman GR; Braeckman R; Kraut J; Shupien S; Craft JC
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2345-51. PubMed ID: 1666497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disposition of guanadrel in subjects with normal and impaired renal function.
    Halstenson CE; Opsahl JA; Abraham PA; Schwenk MH; Andreadis NA; Antal EJ; Matzke GR
    J Clin Pharmacol; 1989 Feb; 29(2):128-32. PubMed ID: 2715368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of meropenem in patients with various degrees of renal function, including patients with end-stage renal disease.
    Chimata M; Nagase M; Suzuki Y; Shimomura M; Kakuta S
    Antimicrob Agents Chemother; 1993 Feb; 37(2):229-33. PubMed ID: 8452352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
    Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
    Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosing Recommendations for Vancomycin in Children and Adolescents with Varying Levels of Obesity and Renal Dysfunction: a Population Pharmacokinetic Study in 1892 Children Aged 1-18 Years.
    Smit C; Goulooze SC; Brüggemann RJM; Sherwin CM; Knibbe CAJ
    AAPS J; 2021 Apr; 23(3):53. PubMed ID: 33839974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.